Two Americans with Ebola received at least half of the world’s supply of a drug that might be able to change the course of the deadly virus.
Some people are asking how to allocate additional doses of this drug and whether it was ethical to give those drugs to American missionaries when they weren’t available to West Africans suffering from or fighting the outbreak.
The World Health Organization will convene a panel of medical ethicists early next week to discuss the use of such experimental treatments. The group will probably decide how to allocate medications should more become available.
Read it all.
(USA Today) Experimental Ebola therapies raise ethical questions
Two Americans with Ebola received at least half of the world’s supply of a drug that might be able to change the course of the deadly virus.
Some people are asking how to allocate additional doses of this drug and whether it was ethical to give those drugs to American missionaries when they weren’t available to West Africans suffering from or fighting the outbreak.
The World Health Organization will convene a panel of medical ethicists early next week to discuss the use of such experimental treatments. The group will probably decide how to allocate medications should more become available.
Read it all.